Neuroprotective signaling pathways are modulated by adenosine in the anoxia tolerant turtle by Nayak, Gauri H et al.
Neuroprotective signaling pathways are modulated
by adenosine in the anoxia tolerant turtle
Gauri H Nayak
1, Howard M Prentice
2 and Sarah L Milton
3
1Department of Biology, Boston University, Boston, Massachusetts, USA;
2College of Biomedical Sciences,
Florida Atlantic University, Boca Raton, Florida, USA;
3Department of Biological Sciences,
Florida Atlantic University, Boca Raton, Florida, USA
Cumulative evidence shows a protective role for adenosine A1 receptors (A1R) in hypoxia/ischemia;
A1R stimulation reduces neuronal damage, whereas blockade exacerbates damage. The signal
transduction pathways may involve the mitogen-activated protein kinase (MAPK) pathways and
serine/threonine kinase (AKT), with cell survival depending on the timing and degree of upregulation
of these cascades as well as the balance between pro-survival and pro-death pathways. Here, we
show in vitro that extracellular signal-regulated kinase (ERK1/2) and phosphatidylinositol 3-kinase
(PI3-K/AKT) activation is dependent on A1R stimulation, with further downstream effects that
promote neuronal survival. Phosphorylated ERK1/2 (p-ERK) and AKT (p-AKT) as well as Bcl-2
are upregulated in anoxic neuronally enriched primary cultures from turtle brain. This native
upregulation is further increased by the selective A1R agonist 2-chloro-N-cyclopentyladenosine
(CCPA), whereas the selective antagonist 8-cyclopentyl-1,3-dihydropylxanthine (DPCPX) decreases
p-ERK and p-AKT expression. Conversely, A1R antagonism resulted in increases in phosphorylated
JNK (p-JNK), p38 (p-p38), and Bax. As pathological and adaptive changes occur simultaneously
during anoxia/ischemia in mammalian neurons, the turtle provides an alternative model to analyze
protective mechanisms in the absence of evident pathologies.
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Introduction
Owing to their high basal oxygen requirements,
neurons are extremely sensitive to ischemic insult.
Any interruption in blood flow to the brain results in
a rapid depletion of oxygen, which severely compro-
mises ATP production and leads to failure of ionic
conductance and excitotoxicity (Lee et al, 2000).
Neurons respond to compromised oxygen availabil-
ity by triggering a dynamic network of signaling
pathways including the mitogen-activated protein
kinases (MAPKs) and phosphatidylinositol 3-kinase
(PI3-K/AKT). The MAPKs constitute a superfamily
of proline-directed serine/threonine kinases that
includes the extracellular signal-regulated kinases
(ERK) and the stress-activated protein kinases (such
as JNK/SAPK1 and p38/SAPK2). The MAPKs control
numerous intracellular events in response to external
stimuli, ultimately changing cell function through
altered gene expression or the posttranslational
modification of proteins (Martindale and Holbrook,
2002). Activation of the MAPKs and PI3-K/AKT
involves phosphorylation and takes place in re-
sponse to a variety of stressors including oxidative
stress and anoxia (Clerk et al, 1998; Kamada et al,
2007).
The ERK signaling cascade has been extensively
studied in several cell types; activation of ERK has
been found to be protective in PC12 cell and rat
ischemic models (Xia et al, 1995; Irving et al, 2000),
though others have found ERK activation promotes
cell death after ischemia (Wang et al, 2003; Zhuang
and Schnellmann, 2006; Sawe et al, 2008). Activa-
tion of the ERK pathway is thus implicated in both
neuronal survival and death and differences may be
linked to the trigger, dynamics, and duration of its
activation (Martindale and Holbrook, 2002; Ho et al,
2007). Rapid and transient activation of ERK seems
to be pro-survival (Li et al, 2002), whereas long-term
activation apparently promotes cell death (Wang
et al, 2003). The role of other MAPK pathways is
also under debate, with investigations reporting JNK
and p38 as apoptosis inducers (Guan et al, 2006),
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and p38 in different mammalian ischemic models
(Dougherty et al, 2002; Beguin et al, 2007).
The PI3-K/AKT is generally reported to be anti-
apoptotic (Zhao et al, 2006); in part through its
interactions with the Bcl-2 family of proteins.
Activation of the AKT pathway phosphorylates Bad
and suppresses its pro-apoptotic activity in both
in vivo ischemic models (Miyawaki et al, 2008) and
in vitro (Datta et al, 1997). Studies reveal that a high
degree of cross-talk exists between the signal trans-
duction pathways, however, and alteration of one
pathway will affect other pathways and thus influ-
ence the outcome after ischemia/reperfusion.
Determining whether a particular pathway is pro-
survival or pro-apoptotic in mammalian models,
however, is difficult, in part because they simulta-
neously exhibit both physiological and pathological
responses to such stressors as hypoxia, ischemia, or
oxidative stress. But such events can be dissected and
analyzed in the anoxia tolerant freshwater turtle,
which survives extended anoxia and postanoxic
reoxygenation without brain damage (Lutz and Mil-
ton, 2004; Kesaraju et al, 2009). It is thus likely in such
a model that modulation of a particular molecular
signaling cascade is adaptive rather than pathological.
Determining survival mechanisms in such an alter-
native animal might help to disentangle the complex-
ities of vulnerable mammalian neurons and provide
insights into the mechanisms of mammalian anoxic
brain damage and survival, including critical up-
stream signals that regulate intracellular events.
One signaling molecule thought to affect AKT and
the MAPK pathways is adenosine (AD), a neuropro-
tectant rapidly formed during ischemia as a result
of the intracellular breakdown of ATP (Dunwiddie
and Masino, 2001). AD has a role in preconditioning
in the brain (Ciccarelli et al, 2007) and heart
(Downey et al, 2007). Recent studies have shown
that activation of AKT confers protection during
adenosine mediated and myocardial ischemic pre-
conditioning (Ban et al, 2008); however, the intra-
cellular signaling pathways mediating the protective
effects of adenosine are still under investigation
(Brust et al, 2006). In turtles, it has been shown that
AD is critical at the physiological level to anoxic
neuronal survival, acting as a ‘retaliatory metabolite’
to balance energy supply and demand (Nilsson and
Lutz, 1991). The AD levels increase as much as 12-
fold over the initial 1 to 2hours anoxia (Nilsson and
Lutz, 1991) accompanied by an increase in A1
receptor (A1R) sensitivity (Lutz and Manuel, 1999).
The ADR activation modulates extracellular levels of
excitotoxins (Milton et al, 2002; Milton and Lutz,
2005) and is a key element of channel arrest (Pek and
Lutz, 1997). We have also recently reported that AD
affects MAPK and AKT levels in the turtle brain
in vivo where an initial upregulation of phosphory-
lated ERK1/2 (p-ERK) and p-AKT and suppression
of p-p38MAPK were blocked by the general
AD antagonist aminophylline (Milton et al, 2008),
whereas blockade of the AD A1R increased cell death
and reactive oxygen species (ROS) release in cul-
tured turtle neurons (Milton et al, 2007). Similarly,
investigations in mammalian models reported that
purinergic activation of ERK and AKT pathways
mediate ischemic preconditioning in heart (Germack
et al, 2004), whereas AD-mediated suppression of
p38 and Bad was reported in astrocytes exposed to
oxygen glucose deprivation (Ciccarelli et al, 2007).
By contrast, Brust et al (2006) showed that A1R
stimulation inhibits presynaptic neurotransmission
through activation of p38MAPK. We hypothesize
that adenosine activates the pro-survival MAPK
(ERK) and AKT pathways while suppressing the
pro-death MAPK pathways (JNK and p38) in isolated
anoxic turtle neurons. Using phospho-protein-speci-
fic antibodies, we measured changes in the levels
of these activated proteins during anoxia and in the
presence of A1R modulators. In this study, we
expand our earlier studies of general AD-linked
protective mechanisms (Milton et al, 2007, 2008)
by investigating the effects of A1R-specific agonist
and antagonist administration on the MAPKs,
AKT, and the primary modulators of stress-related
apoptosis.
Materials and methods
All experiments were approved by the Florida Atlantic
University Institutional Animal Care and Use Committee.
Juvenile freshwater turtles (4 to 6 inch carapace) were
obtained from a commercial supplier (Clive Longdon,
Tallahassee, FL, USA). Turtles were maintained in fresh-
water aquaria on a 12-hour light–dark cycle and were fed
three times weekly. Animals are killed for cell culture
harvest by decapitation in accordance with the animal care
standards established by the American Veterinary Medical
Association for reptiles.
Cell Culture Preparation
We have successfully isolated and maintained turtle primary
neuronally enriched cell cultures using a density centrifuga-
tion method adopted from Brewer (1997) (Milton et al, 2007).
Briefly, brain tissue was minced aseptically and digested
in a cocktail of enzymes (collagenase (25U/mL), dispase
(0.32U/mL), hyaluronidase (1300U/mL) in 4mL of minimal
essential media containing 10% fetal bovine serum (FBS), 56
units each of penicillin and streptomycin with gentle
rocking for 4hours before centrifugation at 750g for
15minutes in a density gradient at room temperature
(251C) using Optiprep medium (Sigma-Aldrich, St Louis,
MO, USA). The neuronal layer was then plated in culture
dishes with minimal essential media medium containing
FBS and penicillin maintained at 301Ci n5 %C O 2 incubator
(Kendro Laboratory Products, Asheville, NC, USA). Survival
rates were B75% beyond 4 days in vitro (DIV). Immunos-
taining with the neuronal markers NeuN and NCAM and the
glial marker GFAP confirmed that cultures are consistently
>85% neuronal cells.
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To confirm the neuronal phenotype, cultured neurons were
double immunostained with primary antimouse NeuN anti-
body, antirabbit neurofilament and antirabbit cysteine string
protein neuronal markers. Alexa Fluor 568 goat antimouse or
antirabbit antibodies (Invitrogen, Molecular probes, Eugene,
OR, USA) were used as secondary antibodies. Briefly, cells
were fixed with 1 to 2mL of freshly prepared 4% para-
formaldehyde for 10minutes. Cells were washed three times
with phosphate-buffered saline and further permeabilized
with 0.1% Triton X-100 in phosphate-buffered saline at room
temperature. Cells were then washed with 0.1% Triton X-100
and nonspecific binding was blocked with blocking solution
(0.5% bovine serum albumin in phosphate-buffered saline
for 15minutes. Cells were incubated overnight at 41Cw i t h
primary antimouse NeuN and antirabbit neurofilament/
cysteine string protein antibodies (Chemicon, Billerica, MA,
USA). After washings, this was followed by Alexa Fluor 568
goat antimouse/rabbit-secondary antibodies used for 1hour in
a 1:1000 dilution. After further washings, cells were prepared
with Vectashield mounting medium (Vector laboratories, Inc.,
Burlingame, CA, USA) and coverslipped. Cells were observed
using a confocal microscope equipped for epifluorescence.
Experimental Treatments
Cell cultures were used at B14 DIV and existing media
was replaced with minimal essential media containing the
specific A1R blocker 8-cyclopentyl-1,3-dihydropyl-
xanthine (DPCPX, 1nmol/L) or the A1R agonist 2-chloro-
N-cyclopentyladenosine (CCPA, 0.6nmol/L). Cells were
then subjected to experimental conditions including
normoxia (maintained at room temperature), or 1, 4, or
12hours anoxia in an anoxia chamber (Bactron Environ-
mental Hypoxia Chamber, Sheldon Manufacturing, Corne-
lius, OR, USA) under anoxic gas mixture (90% N2,5 %H 2,
5% CO2, AirGas, Miami, FL, USA). Continuous monitoring
of oxygen is performed with an OM-4 oxygen meter
(Microelectrodes Inc., Bedford, NH, USA), which ensures
that the chamber is anoxic. Culture plates established from
the same turtles and exposed simultaneously to experi-
mental conditions without the drugs were used as controls.
Protein Extractions
For protein extraction, neurons were washed with ice-cold
phosphate-buffered saline. Cells were further treated with
50mL of RIPA lysis buffer (5mmol/L EDTA, pH 8.0,
0.15mol/L NaCl, 1% Triton X-100, 10mmol/L Tris-Cl,
2mmol/L protease inhibitor pH 7.4) and scraped into
individual tubes on ice for 10minutes. The samples were
triturated and centrifuged for 10minutes at 18,500g at 41C.
The supernatant was then frozen at 801C until use. The
protein concentration was determined by standard BCA
protein assay (Pierce Biotechnology, Rockford, IL, USA).
Immunodetection
Proteins were detected by standard Western blot as
described earlier, using horseradish peroxidase (HRP)-
conjugated secondary antibodies (Milton et al, 2008). The
rabbit polyclonal antibodies for the nonphosphorylated
MAPKs and rabbit Bax polyclonal antibody were pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). These included ERK1/2 (SC-93), JNK1 (SC-571),
p38MAPK (SC-535), and Bax (SC-526). Rabbit polyclonal
antibody to AKT (#9272) and phosphorylated antibodies
phospho-AKT (#9271), phospho-p38MAPK (#4631),
phospho-JNK (#4671), phospho-ERK1/2 (#4376), all were
from Cell Signaling Technology (Danvers, MA, USA).
Antirabbit Bcl-2 antibody was from Chemicon (Temecula,
CA, USA).
The protein-secondary antibody complexes were identi-
fied using a chemiluminescent system (GE Healthcare,
Piscataway, NJ, USA). Densitometric analysis was con-
ducted using National Institute of Health Image J 1.60
software and band densities expressed as a percentage of
the b-actin signal. Actin was used as a loading control,
and its expression remained unchanged in all experimental
conditions. Earlier studies in our laboratory have
also indicated that b-actin levels do not change with
anoxia or reoxygenation in this model (Milton et al,
2008). Data are expressed as percent change of the control
group.
Statistically significant differences between treatments
were determined by analysis of variance with post hoc
analysis using the SPSS statistical package. Differences
were considered statistically significant at P<0.05.
Results
We performed double-labeled immunostaining using
NeuN, neurofilament, and cysteine string protein
neuronal markers. Figure 1A clearly indicates
the neuronal nuclei (green) and localization of the
neuronal filaments in cytoplasm (red), and Figure 1B
shows neuronal nuclei (green) and cysteine string
protein (red) in the neuronal cytoplasm thus con-
firming the neuronal identity of our cultures.
Alterations in Mitogen-Activated Protein Kinase/AKT
Protein Levels in Normoxia and Anoxia Without
Adenosine Receptor Agonists and Antagonists
Baseline: We observed significant changes in all the
activated/phosphorylated MAPKs/AKTin turtle neu-
ronally enriched cell cultures, though the changes
in cell culture occurred more slowly and to a lesser
degree than was reported in the whole brain (Milton
et al, 2008). Increases in the protein levels of
presumed pro-survival pathways p-ERK and p-AKT
(Figures 3A and 4A) were higher than those
thought to be primarily pro-death: p-p38 and p-JNK
(Figures 5A and 6A). Basal anoxic levels of the
nonphosphorylated MAPKs and AKT in cell culture
were generally not different from normoxia in
untreated controls; the levels of actin also remained
unchanged in all experimental conditions, indicat-
ing that the increases in protein levels were not a
generalized stress effect on the cells (Figure 2).
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ing significantly to 374%±11% of normoxic controls
by 1hour anoxia. The p-ERK levels reached
440%±9% by 4hours anoxia before decreasing to
308%±18% by 12hours anoxia (Figure 3). Nonpho-
sphorylated ERK expression in anoxia did not
change significantly from normoxic controls.
AKT/p-AKT: Levels of the presumed pro-survival
p-AKT protein levels also increased rapidly in
anoxia, more than doubling in the first hour of
anoxia and increasing further to 318%±11% by
4hours of anoxia (Figure 4). The levels dropped
slightly but were still elevated after 12hours of
anoxia. Levels of nonphosphorylated AKT did not
change significantly in any experimental conditions.
p38/p-p38: Active p-p38 levels increased to
178%±11% of basal by 4hours anoxia, with a slight
decrease by 12hours anoxia to 161%±7% of
normoxic control (Figure 5). Levels of nonpho-
sphorylated p38MAPK also increased significantly
(about twofold) by 4hours of anoxia, but decreased
toward basal by 12hours of anoxia.
JNK/p-JNK: As with p-p38, we observed a significant
increase to 194%±6% over basal in p-JNK by 4hours
anoxia, which also decreased by 12hours anoxia to
only 154%±10% of normoxic levels (Figure 6).
Levels of nonphosphorylated JNK did not change
significantly in anoxia.
Bcl-2/Bax: The Bcl-2 to Bax ratio is a critical factor
whose balance determines cell survival or death
through apoptosis. In this study, we observed
significant increases in both Bcl-2 and Bax levels
when subjected to anoxic conditions. The increase
in Bcl-2 was relatively higher (182%±12%;
Figure 7B) compared with Bax levels, which in-
creased only to 142%±10% of normoxia by 4hours
anoxia (Figure 7D).
Figure 1 (A) Merged image (40) of double-labeled NeuN (green) and neurofilament (red) immunostaining showing the NeuN-
positive neuronal nuclei and neuronal filaments in the cytoplasm. Scale bar=25mm. (B) Merged image (40) of double-labeled
NeuN (green) and cysteine string protein (red) in the neuronal cytoplasm showing NeuN-positive neuronal nuclei and cysteine string
proteins. Scale bar=25mm. The color reproduction of this figure is available on the html full text version of the manuscript.
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Figure 2 Representative Western blot showing expression of
b-actin in turtle neuronally enriched cell cultures. Actin expression
is unchanged in all experimental conditions. C, controls; CCPA,
2-chloro-N-cyclopentyladenosine; CP , CCPA treated; DP , DPCPX
treated; DPCPX, 8-cyclopentyl-1,3-dihydropylxanthine.
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Figure 3 Representative Western blot of phosphorylated extra-
cellular signal-regulated kinase (p-ERK) (A) and densitometric
analyses (B) of p-ERK1/2 levels under control and experimental
conditions (treated with ADR agonist and antagonist) in turtle
neuronally enriched cell cultures. All normoxia, 1, 4, and
12hours anoxia all on a single gel C, controls; DP , DPCPX
treated; CP , CCPA treated. Data are mean±s.e.m., N=5
independent experiments/group. A=significant difference from
normoxia control for the same treatment, P<0.05; B=sig-
nificant difference from controls at the same time point;
C=significant difference from controls at that point and DPCPX,
P<0.05. CCPA, 2-chloro-N-cyclopentyladenosine; DPCPX,
8-cyclopentyl-1,3-dihydropylxanthine.
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Pathway Components After Exposure to Adenosine
Receptor Agonists and Antagonists
2-Chloro-N-Cyclopentyladenosine/8-Cyclopentyl-1,3-
Dihydropylxanthine exposures: Inhibition of
adenosine receptors with the specific adenosine
A1R antagonist DPCPX significantly suppressed the
activation of the presumed pro-survival signaling p-
ERK cascade and moderately decreased p-AKT levels
compared with untreated anoxic controls, and re-
sulted in the dramatic suppression of Bcl-2 protein
levels (Figure 7). The suppression of p-ERK and
p-AKT occurred simultaneously with moderately
increased activation of the pro-death p38MAPK
cascade and also increased the levels of the pro-
apoptotic Bax. The A1R blockade, however, had no
significant effect on p-JNK levels. Conversely, p-AKT
and p-ERK levels were greater in cells treated with
CCPA than anoxic controls, whereas p-p38 and
p-JNK levels were lower. Neither drug treatment
significantly affected the levels of nonphosphorylated
Akt or the MAPK in general, except for an increase
in nonphosphorylated JNK with DPCPX exposure at
12hours anoxia. The levels of actin also remained
unchanged in all experimental conditions, indicating
that the increases in protein levels were not a
generalized treatment effect on the cells (Figure 2).
ERK/p-ERK: Compared with the other MAPKs and
AKT, the greatest effects from the manipulation of
A1Rs with DPCPX and CCPA were on p-ERK levels.
The p-ERK levels increased to 440%±10% by 1hour
anoxia in CCPA-treated cells (Figure 4B) and
remained elevated through 12hours anoxia. The
native increases in p-ERK activation were signifi-
cantly suppressed by treatment with DPCPX, such
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Figure 4 Representative Western blot of p-AKT (A) and
densitometric analyses (B) of p-AKT levels under control and
experimental conditions (treated with ADR agonist and antago-
nist) in turtle neuronally enriched cell cultures. Normoxia, 1, 4,
and 12hours anoxia all on different gels. C, controls; DP , DPCPX
treated; CP , CCPA treated. Data are mean±s.e.m., N=5
independent experiments/group. A=significant difference from
normoxia control for the same treatment, P<0.05; B=sig-
nificant difference from controls at the same time point;
C=significant difference from controls at that point and DPCPX,
P<0.05. CCPA, 2-chloro-N-cyclopentyladenosine; DPCPX,
8-cyclopentyl-1,3-dihydropylxanthine.
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Figure 5 Representative Western blot of p-p38 (A) and
densitometric analyses (B) of p-p38MAPK levels under control
and anoxic experimental conditions (treated with ADR agonist
and antagonist) in turtle neuronally enriched cell cultures.
Normoxia, 1, 4, and 12hours anoxia samples all on a single
gel. C, controls; DP , DPCPX treated; CP , CCPA treated. Data
are mean±s.e.m., N=5 independent experiments/group.
A=significant difference from normoxia control for the same
treatment, P<0.05; B=significant difference from controls at
the same time point; C=significant difference from controls at
that point and DPCPX, P<0.05; and D=significant difference
from DPCPX, P<0.05. CCPA, 2-chloro-N-cyclopentyladeno-
sine; DPCPX, 8-cyclopentyl-1,3-dihydropylxanthine; MAPK,
mitogen-activated protein kinase.
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Figure 6 Representative Western blot of p-JNK (A) and
densitometric analyses (B) of p-JNK levels under control and
experimental conditions (treated with ADR agonist and antago-
nist) in turtle neuronally enriched cell cultures. Normoxia, 1, 4,
and 12hours anoxia samples all on a single gel. C, controls;
DP , DPCPX treated; CP , CCPA treated. Data are mean±s.e.m.,
N=5 independent experiments/group. A=significant difference
from normoxia control for the same treatment, P<0.05;
B=significant difference from controls at the same time point;
C=significant difference from controls at that point and DPCPX,
P<0.05. CCPA, 2-chloro-N-cyclopentyladenosine; DPCPX,
8-cyclopentyl-1,3-dihydropylxanthine.
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moxic levels at 1, 4, and 12hours anoxia (Figure 3).
Treatment with CCPA and DPCPX did not alter the
nonphosphorylated levels of ERK.
AKT/p-AKT: Treatment with CCPA over 1hour
anoxia increased the activated AKT levels slightly
compared with untreated controls; this increase was
not significant until 4hours anoxia. Treatment with
DPCPX decreased native p-AKT increases only
slightly, to 154%±15% and 261%±7% of untreated
controls at 1 and 4hours anoxia, respectively.
The trend was similar at 12hours anoxia; however,
the differences in treated cells were not significantly
different from untreated anoxic controls (Figure 4).
Levels of the nonphosphorylated AKT remained
unchanged in cultures treated with DPCPX or
CCPA.
p38/p-p38: Manipulation of the A1R resulted in
relatively small effects on p38MAPK compared with
p-ERK or p-AKT. Treatment with CCPA decreased
p-p38 levels below untreated anoxic controls at 4 and
12hours anoxia, but had no effect in normoxic cells
or at 1hour anoxia (Figure 5). Treatment with DPCPX
significantly increased the p-p38 levels by 1 and
4hours anoxia (210%±15% and 224%±7%, respec-
tively) compared with their respective controls. The
p-p38 levels at 12hours anoxia were still elevated,
but the differences were not significant from the
controls at the same time point.
JNK/p-JNK: As was seen in the whole brain (Milton
et al, 2008), manipulation of A1R had the least effects
on p-JNK levels. The activated levels of JNK were
only modestly but nonetheless significantly sup-
pressed by CCPA at 4 and 12hours anoxia (Figure 6),
to 78% and 65% of anoxic controls, respectively,
whereas increases in p-JNK in cells treated with A1R
antagonist DPCPX were not significant at any time
point. Nonphosphorylated JNK levels were unaltered
by treatment with DPCPX in 1 and 4hours anoxia,
though a significant increase of about twofold was
observed by 12hours anoxia compared with un-
treated levels at the same time point. The JNK levels
were reduced by pretreatment with CCPA; however,
the suppression was not significant compared with
the controls.
Alterations in Pro and Antiapoptotic Pathway
Components After Exposure to Adenosine Receptor
Agonists and Antagonists
Bcl-2/Bax: We observed an increase in antiapoptotic
Bcl-2 levels in cells pretreated with CCPA at all time
points. This increase was significant by 1hour anoxia
(152%±18%) and increased to 185%±12% by 4hours
anoxia; these levels remained elevated at 12hours
anoxia (Figure 7B). Conversely, exposing the cells to
DPCPX decreased Bcl-2 levels to 75% of untreated
controls by 4hours anoxia. The CCPA and DPCPX had
the opposite effects on Bax expression: pretreatment
with CCPA decreased Bax levels, whereas DPCPX
increased Bax by 4 and 12hours anoxia to 193%±11%
and 200%±15%, respectively (Figure 7D) compared
with their controls at that time point. Thus, in cultures
treated with the A1R antagonist, the Bcl-2/Bax ratio
decreased from 1.28 in untreated anoxic controls to
0.71 at 4hours anoxia and 0.95 in extended anoxia,
whereas CCPA increased the ratio to 2.0 at 4hours
anoxia and 1.5 by 12hours anoxia.
Discussion
Although the physiology of anoxic survival in
freshwater turtles such as Trachemys scripta and
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Figure 7 Representative Western blots of Bcl-2 and Bax (A, C)
and densitometric analyses (B, D) of Bcl-2 and Bax levels under
control and experimental conditions (treated with ADR agonist
and antagonist) in turtle neuronally enriched cell cultures.
Normoxia, 1, 4, and 12hours anoxia samples all on a single
gel. C, controls; DP , DPCPX treated; CP , CCPA treated. Data are
mean±s.e.m., N=5 independent experiments/group. A=sig-
nificant difference from normoxia control for the same treatment,
P<0.05; B=significant difference from controls at the same
time point; C=significant difference from controls at that point
and DPCPX, P<0.05; and D=significant difference from
DPCPX, P<0.05. CCPA, 2-chloro-N-cyclopentyladenosine;
DPCPX, 8-cyclopentyl-1,3-dihydropylxanthine.
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studies have looked at molecular adaptations in the
turtle brain. In vivo activation of MAPKs (Greenway
and Storey, 2000), and the suppression of Bax
(Haddad, 2007; Kesaraju et al, 2009) in hypoxia have
been reported but links between the physiology and
molecular pathways are even less well studied. We
previously reported that initial in vivo increases in
p-ERK and p-AKT activation, and the suppression of
p-p38, could be abrogated by the general AD receptor
blocker aminophylline (Milton et al, 2008). We have
also reported that the AD agonist CCPA protects
neuronally enriched cultures, whereas the AD blocker
DPCPX increases cell death under conditions of
oxidative stress (Milton et al, 2007). With treatments
similar to those presented in this paper, cell death
increased from B10% in normoxic cells (control and
drug treatments) to 25% in untreated cells after
12hours anoxia/reoxygenation, but was >50% in
DPCPX-treated cells (Milton et al, 2007). In this study,
we expanded on those findings using neuronally
enriched primary cell cultures to examine interactions
between the specific adenosine A1R and the MAPK
pathways, as well as the downstream regulators of
apoptosis, Bcl-2 and Bax. In general, we found that
the MAPK and AKT pathways in vitro responded
similarly to the anoxic brain in vivo,t h o u g ht h e
changes were slower and less dramatic than in the
whole brain, and were sustained over the long term
rather than elevated only temporarily. The ERK and
AKT pathways increased significantly in the initial
hour of anoxia, and these levels were further
increased threefold to fourfold over normoxic levels
after 4hours of anoxia. By contrast, we observed a
sixfold increase in p-ERK in the first hour of anoxia in
vivo, which returned to normoxic levels by 4hours
anoxia (Milton et al, 2008). Changes in p-AKTin vitro
were in line with whole brain induction (AKT in vivo
increased to 323% of basal by 1hour anoxia (Milton et
al, 2008), though again in cell culture this elevation
was sustained rather than temporary.
In contrast to the whole brain, we also observed a
moderate increase in p38 and JNK activation in the
cell cultures, though the increases were less than for
the presumed pro-survival kinases. These results are
similar to those observed in mammalian models
where hypoxia/ischemia leads to the activation of all
the MAPKs (Irving et al, 2000; Li et al, 2002; Wang
et al, 2003), and together with the sustained MAPK
activation suggests that the cells in culture are under
more physiological stress during anoxia than is the
intact brain, most likely due to the lack of glial
support or such whole body adaptations as buffering
capacity.
Mammalian hypoxia/ischemia experimental mod-
els to date have examined the role of MAPK and AKT
signaling cascades in determining the outcome of
cerebral ischemia. However, the triggers to the
activation of these complex cascades in the brain
have not been widely investigated. Fewer studies
have focused on the immediate effects of adenosine
on preventing neuronal cell death after ischemia in
mammals, though these studies support our results
showing A1R protection occurring through the
upregulation of ERK and AKT and the suppression
of p38MAPK (Gervitz et al, 2002; Ciccarelli et al,
2007; Ban et al, 2008). A reduction in blood flow to
the mammalian brain during hypoxia/ischemia
causes a steep elevation in the extracellular levels
of adenosine as ATP breaks down; adenosine in
turn acts as a neuroprotectant (Canals et al, 2005;
Dunwiddie and Masino, 2001). Unlike mammals,
however, the adenosine increase in the turtle brain is
temporary (Nilsson and Lutz, 1991). By 4hours
anoxia, the turtle has entered a fully hypometabolic
state, in which energy consumption is suppressed to
match anaerobic energy production, allowing ATP
levels to return to normal (see reviews Lutz and
Milton, 2004; Milton and Prentice, 2007). Thus, in
the turtle, the initial 1 to 2hours anoxia is a crucial
period of physiological stress, which it survives by
applying a suite of adaptations, and it is during this
transition phase that we see significant molecular
changes, including increases in a variety of heat
shock proteins (Kesaraju et al, 2009) and the MAPK
reported here. The initial in vivo increases in p-ERK
and p-AKT and the suppression of p-p38 in the first
hour of anoxia in the turtle are linked to AD, and can
be blocked with the general AD receptor antagonist
aminophylline (Milton et al, 2008). A similarly rapid
activation of ERK and AKT in the mammal has a key
role in neuroprotection (Li et al, 2002), but it is
reported that prolonged elevation of ERK increases
cell death in an in vivo rat ischemic model (Wang
et al, 2003). By contrast, the early and prolonged
activation of the PI3-K-AKT pathway leads to
neuronal survival in the rat ischemic model (Shibata
et al, 2002). In contrast to our in vivo work (Milton
et al, 2008), p-ERK activation is sustained in the
primary neuronal cultures, although cell death still
averaged <22% over 4hours anoxia versus <10%
basal cell death in normoxia (Milton et al, 2007).
High survival with sustained elevation of p-ERK may
result from the other accompanying changes we
observed, including increases in p-AKT and Bcl-2,
which overshadowed more modest increases in p-
JNK, p-p38MAPK, and Bax. Alternatively, it may be
that the sustained activation of ERK in mammalian
systems is not a trigger for further cell damage but
rather a symptom of additional stress that culminates
in cell death.
As previously reported in vivo, AD is critical to
survival in cultured neurons; AD1R blockade in-
creases ROS release and cell death, whereas treat-
ment with A1R agonist decreases ROS production
and increased survival in anoxia and anoxia/reox-
ygenation (Milton et al, 2007). Similarly, studies in
mammalian systems have shown that AD is critical
to ischemic survival; AD decreases neurological
damage after ischemia/reperfusion injuries, whereas
AD blockade increases neurological and behavioral
deficits in ischemic rats (Gupta et al, 2002).
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neuroprotective AD effects even in acute ischemia
result from downstream molecular events triggered
by ADR activation, including activation of AKT
(Gervitz et al, 2002) ERK1/2, and other MAP kinases
(Brust et al, 2006). Activation of the ERK pathway
leads to the phosphorylation of a wide range of
cellular substrates and activates transcription of
cAMP response element binding protein, which
activates the pro-survival Bcl-2 and suppresses
apoptotic proteins such as BAD, Bim, and the
caspases (Chan, 2004; Sawe et al, 2008) and prevent
apoptosis. Similarly, the protection offered by AKTis
thought to be in part through its interactions with
the Bcl-2 family of proteins. The AKT targets cAMP
response element binding protein to activate pro-
survival mechanisms (Shibata et al, 2002) and also
phosphorylates BAD (Datta et al, 1997; Chan, 2004;
Kamada et al, 2007), thus preventing its translocation
to the mitochondria, inhibiting the release of apopto-
genic proteins (Wang et al, 2007), and decreasing
other stress pathways (Kamada et al, 2007; Wang
et al, 2007). Ciccarelli et al (2007) have shown that
AD1R reduces apoptosis by suppressing JNK and
p38MAPK, simultaneously activating ERK and AKT,
and decreasing the levels of pro-apoptotic proteins
like Bad while elevating levels of antiapoptotic
Bcl-X(L). The results of this study suggest that the
links between AD and cell survival in anoxia/
ischemia in turtles also occur through the MAPKs
and their downstream effects. In the turtle cultures,
both Bcl-2 and Bax increased along with ERK and
AKT, but with Bcl-2 more strongly upregulated than
Bax, suggesting that the molecular pathways are
tilted towards cell survival even with accompanying
(but smaller) increases in p38MAPK and JNK.
In addition, Bcl-2 has been shown to have a major
role in suppressing cell death during apoptotic and
oxidative stress cell injury by enhancing levels of
antioxidants and suppressing the generation of free
radicals (Lee et al, 2001). In this study, the anoxic
increases in Bcl-2 expression above Bax were
reversed by ADR blockade; ADR blockade is accom-
panied by an increase in ROS production and
doubling of cell death (Milton et al, 2007), implicat-
ing that Bcl-2 protein levels can be altered
by adenosine receptor activation, which might be
directly linked to ROS suppression in species. These
studies suggest that the pathway of ROS suppression
in turtles is similar to that in mammals, but is
expressed more robustly and hence is more success-
ful in protecting turtle neurons against anoxia and
reoxygenation damage.
Thus, in addition to its other myriad neuroprotec-
tive effects in the anoxic turtle brain; we have shown
that activation of ADR receptor also increases cell
survival by modulating molecular pathways in favor
of cell survival. Pretreatment with CCPA increased
activation of ERK and AKT, which further lead to
elevation of Bcl-2, inhibition of Bax, and reduced
activation of p-p38; these changes in turn are thought
to stabilize the mitochondria and reduce ROS release
(Gervitz et al, 2002; Brust et al, 2006). The overall
observations from earlier investigations and this
current study clearly indicate a link between the
physiological mechanisms of survival (elevated AD,
low ROS) and molecular adaptations in this anoxia
tolerant model. Through utilization of an animal
model of anoxia tolerance, honed for survival by
millions of years of adaptation, and investigating
the differences between in vivo and in vitro survival,
it is clear that increases in p-ERK and p-AKT
(pro-survival pathways), and a reduction of activated
p38 (pro-death pathway) through ADR stimulation,
promote neuronal survival, and that continued high
levels of ERK is not necessarily a trigger of cell death
if other molecular changes are sufficient to promote
survival. The use of an alternative animal model,
able to survive extended anoxia and reoxygenation
with minimal cell death, allows us to more clearly
distinguish between pro-survival and pathological
responses in anoxic neurons.
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